drugset / Trial / NCT04956627

A Study to Assess the Effect of Itraconazole, Phenytoin and Gemfibrozil on the Drug Levels of BMS-986166 in Healthy Participants

NCT04956627

Phase 1 Completed 15 enrolled Bristol-Myers Squibb
RandomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to evaluate the effect of itraconazole, phenytoin and gemfibrozil on the drug levels of BMS-986166 and its active metabolite BMT-121795. Participants will be randomly assigned to one of four groups and will remain in the study clinic for the duration of treatment.

Timeline

Start
2021-07-28
Primary completion
2022-04-27
Completion
2022-04-27

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-986166 Small molecule
Subject Gemfibrozil Small molecule
Subject Itraconazole Small molecule
Subject Phenytoin Unknown

Indications

No indication recorded.